OCS:NASDAQ, Oculis Holding AG

OCS stock overview

Oculis Holding AG (OCS:NASDAQ) closed at $7.49 on November 6, 2026, up 9.66% on the day. The stock trades 78.3% below its 52-week high of $34.48 and 10.5% above its 52-week low of $6.78. Over the past year, it lost 61.4%. Oculis Holding AG is part of the Health Care sector.

Key figures

Price
$7.49
Day change
+9.66%
Volume
404,086
Average volume
263,132
Market cap
417M+
52-week range
$6.78 – $34.48
50-day average
$9.29
200-day average
$18.46

Price action over the past year

In 252 trading sessions since November 6, 2025, OCS closed higher on 123 days (49%). Its best day was May 21, 2026 (+11.07%) and its worst was June 1, 2026 (-36.09%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

OCS news

About Oculis Holding AG

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Similar stocks

Find more stocks like OCS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.